Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: Am J Cardiol. 2014 Jul 1;114(6):843–848. doi: 10.1016/j.amjcard.2014.06.012

Table 3.

Hazard ratios for cause-specific mortality per SD of FFA in Cardiovascular Health Study

Number of vents HR Model 1 95% CI p-value HR Model 2 95% CI p-value
Cardiovascular 1,155 1.08 (1.01, 1.14) 0.02 1.08 (1.01, 1.15) 0.02
Cancer 729 1.02 (0.95, 1.11) 0.55 1.05 (0.96, 1.14) 0.29
Dementia 502 1.27 (1.16, 1.39) <0.001 1.32 (1.20, 1.44) <0.001
Infection 288 1.23 (1.09, 1.38) 0.001 1.25 (1.10, 1.41) 0.001
Respiratory 199 1.26 (1.10, 1.45) 0.001 1.23 (1.06, 1.43) 0.007
Trauma 156 0.97 (0.82, 1.16) 0.77 0.99 (0.83, 1.19) 0.93
Other 322 1.11 (0.99, 1.24) 0.08 1.16 (1.03, 1.31) 0.02

CI=confidence interval; FFA=free fatty acids, HR=hazard ratio; SD=standard deviation SD of FFA = 0.2mEq/L. Total person-years = 54,167. Model 1: adjusted for age, sex, race, clinic and education (n = 4707). Model 2: adjusted for age, sex, race, clinic, education, BMI, cystatin C, albumin, physical activity, alcohol intake, smoking, hormone replacement therapy, self-reported health status, systolic blood pressure, LDL cholesterol, HDL cholesterol, hypertensive medication and lipid-lowering medication (n = 4620). Types of mortality were defined as: cardiovascular (coronary heart disease, stroke, or other atherosclerotic disease), cancer (any type), dementia, infection (pneumonia, sepsis or other infection), respiratory, trauma (includes fractures) or other (liver disease, gastrointestinal disease, renal failure, ALS, Parkinson’s disease, bladder disease, metabolic conditions, amyloid, failure to thrive, myelodysplastic syndrome, and other musculoskeletal diseases).